Influence of sex on the pharmacokinetics of tolmetin in the rat

Journal of Pharmacological and Toxicological Methods

Volumn 42, Issue 2, 1999, Pages 103-105

  Jiménez, Miguel ^a   Pérez Urizar, José ^b   Flores Murrieta, Francisco J ^b  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Pharmacokinetics; Rat; Sex; Tolmetin

Indexed keywords

KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; TOLMETIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PHARMACOKINETICS; RAT; SEX DIFFERENCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; MALE; RATS; RATS, WISTAR; SEX FACTORS; TOLMETIN;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0342656582     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(00)00050-2     Document Type: Article

References (16)

1. Beierle I., Meibohm B., Derendorf H. Gender differences in pharmacokinetics and pharmacodynamics. Int J Clin Pharmacol Ther. 37:1999;529-547.
2. Berkowitz S.S., Bernhard G., Bilka P.J., Blecham W.J., Marchesano J.M., Rosenthal M., Wortham G.F. Tolmetin versus placebo for the treatment of rheumatoid arthritis. a sequential double-blind clinical trial Curr Ther Res. 16:1974;442-451.
3. Bonate P.L. Gender-related differences in xenobiotic metabolism. J Clin Pharmacol. 31:1991;684-690.
4. Flores-Acevedo D.M., Flores-Murrieta F.J., Castañeda-Hernández G., López-Muñoz F.J. Potentiation of the analgesic effect of tolmetin, a potent non-steroidal antiinflammatory drug by caffeine in the rat. Pharm Sci. 1:1995;441-444.
5. Flores-Murieta F.J., Ko H.C., Flores-Acevedo D.M., López-Muñoz F.J., Jusko W.J., Sale M.E., Castañeda-Hernández G. Pharmacokinetic-pharmacodynamic modeling of tolmetin antinociceptive effect in the rat using an indirect response model. a population approach J Pharmacokinet Biopharm. 26:1998;547-557.
6. Furst D.E., Dromgoole S.H., Desiraju R.K., Paulus H.E. Clinical pharmacology of tolmetin. comparisons in rheumatoid arthritis patients and normal volunteers J Clin Pharmacol. 23:1983;329-335.
7. Granados-Soto V., López-Muñoz F.J., Hong E., Flores-Murrieta F.J. Relationship between pharmacokinetics and the analgesic effect of ketorolac in the rat. J Pharmacol Exp Ther. 272:1995;352-356.
8. Granados-Soto V., Vidal-Cantú G., Flores-Murrieta F.J. Sex-related differences in the pharmacokinetics of oral tolmetin in the rat. Pharm Sci. 2:1996;601-603.
9. Harris R.Z., Benet L.Z., Schwartz J.B. Gender effects in pharmacokinetics and pharmacodynamics. Drugs. 50:1995;222-239.
10. Holck H.G.O., Munir A.K., Mills L.M., Smith E.L. Studies on sex differences in rats in tolerance to certain barbiturates and nicotine. J Pharmacol Exp Ther. 60:1937;323-335.
11. Insel P. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, & A. Goodman Gilman (Eds.). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th(ed. (pp. 617-657). New York: McGraw-Hill):1995.
12. Kato R., Yamazoe Y. Sex-specific cytochrome P-450 as a cause of sex- and species-related differences in drug toxicity. Toxicol Lett. 65:1992;661-667.
13. Nicholas G.S., Barron D.H. The use of sodium amytal in the production of anesthesia in the rat. J Pharmacol Exp Ther. 46:1934;223-226.
14. Ryan D.E., Dixon E., Evans R.H., Ramanathan L., Thomas P.E., Wood A.W., Levin W. Rat hepatic cytochrome P-450 isozymes specificity for the metabolism of the steroid sulfate 5alpha-androstane-3alpha, 17beta-diol-3,17 disulfate. Arch Biochem Biophys. 233:1984;636-642.
15. Thurmann P.A., Hompesch B.C. Influence of gender on the pharmacokinetics and pharmacodynamics of drugs. Int J Clin Pharmacol Ther. 36:1998;586-590.
16. Wong S., Gardocki J.F., Pruss T.P. Pharmacological evaluation of tolectin (tolmetin, McN-2559) and McN-2891, two antiinflammatory agents. J Pharmacol Exp Ther. 185:1973;127-138.